| Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives HA Parray, S Shukla, S Samal, T Shrivastava, S Ahmed, C Sharma, ... International immunopharmacology 85, 106639, 2020 | 184 | 2020 |
| Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B. 1.617. 2) variant surge in India: a test-negative, case-control study and a … R Thiruvengadam, A Awasthi, G Medigeshi, S Bhattacharya, S Mani, ... The Lancet Infectious Diseases 22 (4), 473-482, 2022 | 94 | 2022 |
| A single amino acid change, Q114R, in the cleavage-site sequence of Newcastle disease virus fusion protein attenuates viral replication and pathogenicity S Samal, S Kumar, SK Khattar, SK Samal Journal of General Virology 92 (10), 2333-2338, 2011 | 63 | 2011 |
| Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections HA Parray, S Shukla, R Perween, R Khatri, T Shrivastava, V Singh, ... Applied Microbiology and Biotechnology 105, 6315-6332, 2021 | 61 | 2021 |
| Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library HA Parray, AK Chiranjivi, S Asthana, N Yadav, T Shrivastava, S Mani, ... Journal of Biological Chemistry 295 (36), 12814-12821, 2020 | 58 | 2020 |
| Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection ZA Rizvi, R Dalal, S Sadhu, A Binayke, J Dandotiya, Y Kumar, ... Elife 11, e73522, 2022 | 51 | 2022 |
| Coordinate deletion of N-glycans from the heptad repeats of the fusion F protein of Newcastle disease virus yields a hyperfusogenic virus with increased replication, virulence … S Samal, SK Khattar, S Kumar, PL Collins, SK Samal Journal of virology 86 (5), 2501-2511, 2012 | 46 | 2012 |
| Mutations in the cytoplasmic domain of the Newcastle disease virus fusion protein confer hyperfusogenic phenotypes modulating viral replication and pathogenicity S Samal, SK Khattar, A Paldurai, S Palaniyandi, X Zhu, PL Collins, ... Journal of Virology 87 (18), 10083-10093, 2013 | 40 | 2013 |
| Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs SK Khattar, S Samal, AL DeVico, PL Collins, SK Samal Journal of virology 85 (20), 10529-10541, 2011 | 36 | 2011 |
| Conformational epitope-specific broadly neutralizing plasma antibodies obtained from an HIV-1 clade C-infected elite neutralizer mediate autologous virus escape through … S Patil, R Kumar, S Deshpande, S Samal, T Shrivastava, S Boliar, ... Journal of virology 90 (7), 3446-3457, 2016 | 31 | 2016 |
| Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection R Kumar, T Shrivastava, S Samal, S Ahmed, HA Parray Applied microbiology and biotechnology 104, 3209-3228, 2020 | 28 | 2020 |
| Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and … R Khatri, G Siddqui, S Sadhu, V Maithil, P Vishwakarma, B Lohiya, ... Medical Microbiology and Immunology 212 (1), 103-122, 2023 | 22 | 2023 |
| Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector SK Khattar, S Samal, CC LaBranche, DC Montefiori, PL Collins, SK Samal PloS one 8 (10), e78521, 2013 | 22 | 2013 |
| Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus P Murugavelu, R Perween, T Shrivastava, V Singh, HA Parray, S Singh, ... International Immunopharmacology 99, 108020, 2021 | 17 | 2021 |
| Severe acute respiratory syndrome coronavirus 2 spike protein based novel epitopes induce potent immune responses in vivo and inhibit viral replication in vitro P Vishwakarma, N Yadav, ZA Rizvi, NA Khan, AK Chiranjivi, S Mani, ... Frontiers in immunology 12, 613045, 2021 | 17 | 2021 |
| An efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodies S Boliar, S Das, M Bansal, BN Shukla, S Patil, T Shrivastava, S Samal, ... PLoS One 10 (3), e0122443, 2015 | 16 | 2015 |
| Evaluation of the replication, pathogenicity, and immunogenicity of avian paramyxovirus (APMV) serotypes 2, 3, 4, 5, 7, and 9 in rhesus macaques SK Khattar, B Nayak, SH Kim, S Xiao, S Samal, A Paldurai, UJ Buchholz, ... PloS one 8 (10), e75456, 2013 | 16 | 2013 |
| Cell surface ectodomain integrity of a subset of functional HIV-1 envelopes is dependent on a conserved hydrophilic domain containing region in their C-terminal tail S Samal, S Das, S Boliar, H Qureshi, T Shrivastava, N Kumar, S Goswami, ... Retrovirology 15, 1-19, 2018 | 14 | 2018 |
| Cellular immune responses are preserved and may contribute to Chadox1 ChAdOx1 nCoV-19 vaccine effectiveness against infection due to SARS-CoV-2 B· 1· 617· 2 delta variant … R Thiruvengadam, A Awasthi, G Medigeshi, S Bhattacharya, S Mani, ... | 13 | 2021 |
| Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response T Shrivastava, S Samal, AK Tyagi, S Goswami, N Kumar, G Ozorowski, ... Vaccine 36 (12), 1627-1636, 2018 | 13 | 2018 |
